title: Human papillomavirus and invasive cervical cancer in Brazil.
abstract: A hospital-based case-control study was undertaken to examine the role of human papillomavirus (HPV) in the development of invasive cervical cancer in Brazil. The study included 199 histologically confirmed incident cases and 225 age-frequency-matched controls selected from a wide range of diagnostic categories. A polymerase chain reaction technique was used to detect HPV DNA in cervical specimens collected with spatula and brush. HPV DNA was detected in 84% of the cases compared with 17% of controls. Grouping HPV types 16, 18, 31 and 33, 66% of the cases were positive compared with only 6% of the controls. In addition to HPV, number of sexual partners, early age at first intercourse, parity and duration of oral contraceptive use were significantly associated with an increased risk of cervical cancer. A history of previous Papanicolaou smears was significantly associated with a decreased risk. After adjustment, only presence of HPV DNA, parity and history of previous smears remained as independent risk factors. The adjusted odds ratios of cervical cancer associated with HPV 16, 18, 31, and 33 was 69.7 (95% confidence interval 28.7-169.6) and with unidentified types was 12.0 (5.1-28.5). The very high risks found in this study further implicate this virus in the aetiology of cervical cancer.
authors.affiliation: Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de Sao Paulo, Brazil.
authors.forename: J
authors.initials: J
authors.lastname: Eluf-Neto
authors.forename: M
authors.initials: M
authors.lastname: Booth
authors.forename: N
authors.initials: N
authors.lastname: Muñoz
authors.forename: F X
authors.initials: FX
authors.lastname: Bosch
authors.forename: C J
authors.initials: CJ
authors.lastname: Meijer
authors.forename: J M
authors.initials: JM
authors.lastname: Walboomers
mesh_terms: D000328:Adult; D000368:Aged; D001938:Brazil / Q000453:epidemiology; D016022:Case-Control Studies; D003276:Contraceptives, Oral / Q000009:adverse effects; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005784:Gene Amplification; D005914:Globins / Q000235:genetics; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D027383:Papillomaviridae / Q000235:genetics; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000235:genetics; D016133:Polymerase Chain Reaction; D015995:Prevalence; D012307:Risk Factors; D012747:Sexual Partners; D012907:Smoking / Q000009:adverse effects; D014412:Tumor Virus Infections / Q000453:epidemiology* / Q000235:genetics; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000821:virology
chemical_list: D003276:Contraceptives, Oral; D004279:DNA, Viral; D005914:Globins